USPTO trademark

COV-19 IDX

RegisteredUSPTOWord markClass 5Class 44

"COV-19 IDX" is a word mark owned by Ipsum Diagnostics LLC, filed at the USPTO on September 11, 2020. It is registered and covers classes 5 and 44.

Get this data via the API
Official USPTO record
COV-19 IDX trademark as filed
As filed with the USPTO
Status
Registered
Since September 28, 2021
Filed
September 11, 2020
Registered
September 28, 2021
Expires
Not recorded
Application no.
90173914
Registration no.
6497097
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
2 classes
Ownership

Who owns COV-19 IDX

The owner and representative on file with the office.

Owner

Ipsum Diagnostics LLC

Atlanta, United States

Representative

Michael J. Tempel

Smith Tempel Blaha LLC

Goods and services

What the mark covers

The products and services COV-19 IDX is filed for, grouped by Nice class.

  • Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, SARS-CoV-2 (COVID-19); Diagnostic preparations for medical purposes; all the foregoing related to the diagnosis of COVID-19

  • Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical diagnostic testing, monitoring and reporting services; Medical testing for diagnostic or treatment purposes in the field of SARS-CoV-2 (COVID-19); all the foregoing related to the treatment or diagnosis of COVID-19

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Courtesy reminder - sec. 8 (6-yr) e-mailed
  2. Registered-principal register
  3. Official gazette publication confirmation e-mailed
  4. Published for opposition
  5. Notification of notice of publication e-mailed
  6. Approved for pub - principal register
  7. Teas/email correspondence entered
  8. Correspondence received in law office
  9. Teas response to office action received
  10. Notification of non-final action e-mailed

5 earlier steps on the official record.

FAQ

About COV-19 IDX

Who owns the trademark "COV-19 IDX"?

The USPTO trademark "COV-19 IDX" (application 90173914) is owned by Ipsum Diagnostics LLC.

What is the status of "COV-19 IDX"?

Its status at the USPTO is: registered.

When was "COV-19 IDX" registered?

It was registered on September 28, 2021.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull COV-19 IDX and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2c39-d3b6-721f-8584-75c1e6a1e9db
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2c39-d3b6-721f-8584-75c1e6a1e9db",
  "object": "trademark",
  "mark_text": "COV-19 IDX",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "90173914",
  "filing_date": "2020-09-11",
  "nice_classes": [
    5,
    44
  ],
  "owners": [
    {
      "name": "Ipsum Diagnostics LLC",
      "entity_id": null
    }
  ]
}